Steiner, Thorsten

Idarucizumab for Dabigatran Reversal

Pollack, C. V., Reilly, P. A., Eikelboom, J., Glund, S., Verhamme, P., Bernstein, R. A., Dubiel, R., Huisman, M. V., Hylek, E. M., Kamphuisen, P. W., et al. (2015) · New England Journal of Medicine

Atrial Fibrillation Management and OutcomesBlood Coagulation and Thrombosis Mechanisms

Cited by 1,552

Efficacy and Safety of Recombinant Activated Factor VII for Acute Intracerebral Hemorrhage

Mayer, S. A., Brun, N. C., Begtrup, K., Broderick, J., Davis, S., Diringer, M. N., Skolnick, B. E., & Steiner, T. (2008) · New England Journal of Medicine

Intracerebral and Subarachnoid Hemorrhage ResearchIntracranial Aneurysms: Treatment and Complications

Cited by 1,255

Dichotomized Efficacy End Points and Global End-Point Analysis Applied to the ECASS Intention-to-Treat Data Set: Post Hoc Analysis of ECASS I

Hacke, W., Bluhmki, E., Steiner, T., Tatlisumak, T., Mahagne, M.-H., Sacchetti, M.-L., & Meier, D. (1998) · Stroke

Acute Ischemic Stroke ManagementStatistical Methods in Clinical Trials

Cited by 109

Management of acute stroke in patients taking novel oral anticoagulants

Hankey, G. J., Norrving, B., Hacke, W., & Steiner, T. (2014) · International Journal of Stroke

Atrial Fibrillation Management and OutcomesAcute Ischemic Stroke Management

Cited by 63